Entrust Datacard Completes Purchase of Market-Leading General-Purpose Hardware Security Business, nCipher Security, from Thales
Entrust Datacard, a leading provider of trusted identity and secure issuance technology solutions, completed its previously-announced acquisition of nCipher Security, formerly Thales's market-leading general purpose hardware security module (HSM) business.
The general purpose HSM market is growing quickly, driven by global demand for stronger data and application security, increased encryption, and privacy regulations such as the EU General Data Protection Regulation (GDPR) and the electronic identification, authentication and trust services (eIDAS) regulation. HSMs offer the highest levels of cryptographic security, and are deployed to minimize network and cybersecurity risks from cloud services, Internet of Things (IoT) devices and other digital initiatives.
“We are extremely pleased to complete this acquisition and bring nCipher’s exceptional talent and technology into the Entrust Datacard portfolio. The need for secure network access and data integrity continues to multiply – from mobile devices and cloud services to connected IoT devices and digital payments. The use of HSMs is expanding across all of these domains. With nCipher now part of our solution portfolio, customers will see benefit from our expanded offerings for the most sensitive, high assurance use cases,” said Todd Wilkinson, president and CEO of Entrust Datacard.
General purpose HSMs are a core component of Entrust Datacard's solutions and are an underlying part of the security infrastructure of the company's public key infrastructure (PKI) and secure sockets layer (SSL) offerings. Entrust Datacard will offer the nCipher solution with its on-premise and managed PKI offerings, and its IoT device credentialing, authorization and lifecycle management offerings. By joining Entrust Datacard, nCipher will be able to expand its compliance capabilities from trusted hardware to include trusted identities, and grow its cloud capabilities to offer customers more advanced solutions from Entrust Datacard’s secure hosting facilities.
“nCipher is excited to join the talented Entrust Datacard team. This acquisition quickly expands the global footprint for nCipher solutions and accelerates our strategy for ‘as-a-service’ offerings,” said Cindy Provin, CEO of nCipher Security. “HSMs provide a foundation of trust for business applications such as PKI, blockchain, mobile payments and code signing. As a single company, Entrust Datacard is positioned to effectively secure our customers’ sensitive information and business critical applications as they implement new digital initiatives.”
More than 300 nCipher employees are now part of the Entrust Datacard team. The nCipher Security business will continue to be based in Sunrise, Fla., with a cybersecurity development center in Cambridge, UK and a sales support center in Hong Kong. Additional terms of the acquisition are undisclosed.
For more information about the Entrust Datacard acquisition of nCipher Security, visit: www.entrustdatacard.com/pages/ncipher-acquisition.
About nCipher Security
Today’s fast-moving digital environment enhances customer satisfaction, gives competitive advantage and improves operational efficiency. It also multiplies the security risks.
nCipher Security, a leader in the general purpose hardware security module (HSM) market, empowers world-leading organizations by delivering trust, integrity and control to their business critical information and applications.
Our cryptographic solutions secure emerging technologies – cloud, IoT, blockchain, digital payments – and help meet new compliance mandates, using the same proven technology that global organizations depend on today to protect against threats to their sensitive data, network communications and enterprise infrastructure. We deliver trust for your business critical applications, ensuring the integrity of your data and putting you in complete control – today, tomorrow, at all times. For more information, visit www.ncipher.com.
About Entrust Datacard Corporation
Consumers, citizens and employees increasingly expect anywhere-anytime experiences — whether they are making purchases, crossing borders, accessing e-gov services or logging onto corporate networks. Celebrating 50 years in 2019, Entrust Datacard offers the trusted identity and secure transaction technologies that make those experiences reliable and secure. Solutions range from the physical world of financial cards, passports and ID cards to the digital realm of authentication, certificates and secure communications. With more than 2,200 Entrust Datacard colleagues around the world, and a network of strong global partners, the company serves customers in 150 countries worldwide. For more information, visit www.entrustdatacard.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005937/en/
Contact information
Michelle Morgan-Nelsen
Entrust Datacard, Public Relations
+1
952 988 1796
michelle.morgan-nelsen@entrustdatacard.com
Liz Harris
nCipher Security, Corporate Communications
+44 7973
903648
Liz.Harris@ncipher.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue28.4.2025 14:16:00 EEST | Press release
Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress: Landing Breathe and Xtreme Rescue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428669720/en/ Ettore Sansavini, GVM Care & Research President, and Antonio Petralia, CEO and Executive Vice President of Eurosets, with Xtreme Rescue and Jetson One Landing Breathe is a next-generation capnometer designed to provide comprehensive monitoring of both the mechanical oxygenator lung and the native lung during ECMO (extracorporeal membrane oxygenation) treatments. The device integrates with Landing Advance, which already analyzes 22 metabolic parameters. Thanks to this technology, clinicians can rely on a real-time, full picture of the patient’s respiratory condition, optimizing therapeutic management. Alongside this innovation, Eurosets also presents Xtreme Rescue, a p
Quantum Computing’s Rapid Rise Is a Risk to Cybersecurity and Business Stability – but Organisations Are Unprepared28.4.2025 14:00:00 EEST | Press release
Quantum computing has revolutionary potential; expected to change life as we know it – and is broadly welcomed by 56% of cyber and IT professionals as creating opportunities for business. That’s according to new research from ISACA, the leading global professional association helping individuals and organisations in their pursuit of digital trust. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428853346/en/ ISACA’s 2025 Quantum Computing Pulse Poll features of-the-moment insights from 2,685 global professionals who work in digital trust fields, including cybersecurity, audit, risk or data privacy. This includes 529 respondents from across Europe, providing a focused view on how European organizations perceive and prepare for the quantum future. However, the research revealed that despite a general sense of optimism about its revolutionary potential – as 44% believe quantum will create revolutionary innovations – IT profes
FPT Recognized in The Digital Transformation Services Landscape Report28.4.2025 13:06:00 EEST | Press release
Global IT firm FPT announced its inclusion in Forrester’s The Digital Transformation Services Landscape, Q2 2025. The report provides an overview of 35 digital transformation service providers and offers valuable insights into the current market dynamics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428400623/en/ FPT is recognized as a Notable Provider in the report which stated that transformation leaders can use digital transformation services to “articulate and orchestrate strategy-aligned transformation journeys; align tech modernization with people, organization, and culture change, and navigate transformation risks.” The report notes FPT's geographical focus in North America and Asia-Pacific, along with its industry focus in financial services, IT/Tech services, and manufacturing/production of industrial products. FPT’s suite of digital transformation services includes cutting-edge solutions in AI, cloud computing
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom